China (Mainland)
- Product Details
Keywords
- MSX122
- MSX-122
- RECHEMS
Quick Details
- ProName: MSX 122
- CasNo: 897657-95-3
- Appearance: solid
- Application: Medicinal Chemistry 、 Biomedicine、 Pha...
- DeliveryTime: In-stock
- PackAge: Bottle and bag according to customer
- Port: Shanghai
- ProductionCapacity: Metric Ton/Day
- Purity: 98%
- Storage: Stored in well-closed containers
- Transportation: By express
- LimitNum: 0 Metric Ton
- Valid Period: 3 years when properly stored
Superiority
Details
MSX-122 is an orally active partial antagonist of CXCR4, inhibiting CXCR4/CXCL12 actions, with an IC50 of ∼10 nM. MSX-122 has anti-inflammatory and anti-metastatic activity.
Shanghai Rechem science Co., Ltd.
Rechemsis focus on R&D of new APIS, signal transduction inhibitors and pharmaceutical intermediates. We follow closely the industry trend, and the latest research achievements in life science area.
Rechems is located in the largest biomedical base in China--Shanghai and cooperatively established modern production base and laboratory in surrounding areas. We have built up a good relationship with many US / European / Japanese pharmaceutical companies to conduct chemical research and inventory trading in medicinal chemistry.
Rechems's mission is to serve pharmaceutical community by providing excellent services and high-quality products in a timely manner.
Rechems's vision is to be recognized by our clients as one of the best suppliers of chemical products for our superior quality, efficient and cost-effective services.
We insist the principle of "Quality first, customer foremost, best credit, be pioneering and creative", looking forward to establishing good business relationships with customers all over the world. Let's work together for bright future!
